title: Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes.
abstract: Bile acids (BA) enter cholangiocytes by the Na(+)-dependent apical BA transporter (ABAT). By this mechanism, taurocholate (TC) and taurolithocholate (TLC) increase cholangiocyte proliferation. No in vivo studies exist regarding the anatomical sites involved in BA-regulation of cholangiocyte growth. Specific cholangiocyte subpopulations participate in BA-regulated proliferation. Proliferation was assessed in liver sections by determining the number of proliferating cellular nuclear antigen (PCNA)-positive cholangiocytes and cytokeratin-19 (CK-19)-positive ducts. We isolated small and large cholangiocytes from rats fed for 1 week TC, TLC, or BA control diet and determined PCNA and ABAT expression and BA transport activity. We evaluated if TC and TLC induction of ABAT expression was dependent on activation of PKC alpha. DNA replication was active only in large normal cholangiocytes. TC and TLC feeding increased proliferation of large cholangiocytes, induced the de novo activation of proliferation of small cholangiocytes, overexpression of ABAT and BA transport activity in large cholangiocytes, and de novo expression of ABAT and BA transport activity in small cholangiocytes. BA-stimulated ABAT expression was dependent on PKC activation in cholangiocytes. TC and TLC stimulate proliferation of small and large cholangiocytes associated with PKC-dependent up-regulation of ABAT.
authors.affiliation: Department of Internal Medicine, Scott & White Hospital and The Texas A&M University System Health Science Center, College of Medicine, Temple, TX 76508, USA.
authors.forename: G
authors.initials: G
authors.lastname: Alpini
authors.forename: Y
authors.initials: Y
authors.lastname: Ueno
authors.forename: S S
authors.initials: SS
authors.lastname: Glaser
authors.forename: M
authors.initials: M
authors.lastname: Marzioni
authors.forename: J L
authors.initials: JL
authors.lastname: Phinizy
authors.forename: H
authors.initials: H
authors.lastname: Francis
authors.forename: G
authors.initials: G
authors.lastname: Lesage
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001652:Bile Ducts / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D048429:Cell Size; D006913:Hydroxysteroid Dehydrogenases; D007527:Isoenzymes / Q000502:physiology; D008297:Male; D008562:Membrane Glycoproteins; D011493:Protein Kinase C / Q000502:physiology; D051571:Protein Kinase C-alpha; D051381:Rats; D011916:Rats, Inbred F344; D013656:Taurocholic Acid / Q000494:pharmacology*; D013658:Taurolithocholic Acid / Q000494:pharmacology*; D045002:3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)
chemical_list: D002352:Carrier Proteins; D006913:Hydroxysteroid Dehydrogenases; D007527:Isoenzymes; D008562:Membrane Glycoproteins; D011493:Protein Kinase C; D051571:Protein Kinase C-alpha; D013656:Taurocholic Acid; D013658:Taurolithocholic Acid; C037643:bile acid binding proteins; C435496:AKR1C2 protein, human; D045002:3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)